Position in ANIK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$423,820
-$134,549 QoQ
Shares Held
29,229
-49.7% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $418,627,713 across 21 Drug Manufacturers - Specialty & Generic names. ANIK ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
149,303 | $88,533,692 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
974,210 | $73,893,828 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,318,555 | $68,156,107 | |
| 4 | HLN |
Haleon plc
|
6,574,038 | $65,806,120 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,130,507 | $34,050,870 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
640,958 | $30,862,127 | |
| 7 | VTRS |
Viatris Inc
|
1,777,181 | $24,009,715 | |
| 8 | ADCT |
ADC Therapeutics SA
|
3,382,129 | $12,682,983 |
All Filings in ANIK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $423,820 | 29,229 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $558,369 | 58,103 | Shares | Defined | 2026-02-17 | |
| 2023-09-30 | $259,832 | 13,947 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||